A widely prescribed drug for diabetes, called pioglitazone (marketed as Actos in the United States), is now being investigated by the FDA because it may increase the risk of bladder cancer.  It is already known to increase the risk of liver damage in patients who take it.  It is also known to cause heart failure in some patients.  In spite of all of these possible side effects, the drug is still one of the most prescribed drugs for diabetes because it is only about half as likely to cause heart attacks as its most significant competitor, Avandia.

Amazingly, the FDA has recently prohibited the prescription of Avandia, unless it is being used as a last resort drug where all other diabetes drugs have failed.

Takeda Pharmaceuticals, the manufacturer of Actos, found in a five-year study that patients who take the drug had a ‘non-statistically significant 20%  higher risk of being diagnosed with bladder cancer’ (?!?).  The risk of cancer was higher for patients who had been taking the drug for over 2 years, and was highest for patients who had been exposed to the highest levels.

Once again, it is found that a pharmaceutical drug causes cancer.  This is a recurring pattern because the entire philosophy that supports the use of pharmaceutical drugs is flawed.  There is no way to poison the body back to health.  All pharmaceutical drugs function as poisons to the body.  They can not bring the body to any type of natural balance because none of them are necessary for any bodily function.  They all create many more side effects than any minimal beneficial effects they could ever have on the body.

It is a ‘pipe-dream’ to believe that pharmaceutical drugs can bring one back to optimal health.  They may give a patient temporary relief from disease, but long-term, they cannot succeed in creating balanced health.  They can only make the body more toxic, and if a patient is taking enough of them, they will eventually reach a condition of toxic overload.  This will continue to cause a steady deterioration of the patient’s health condition until the patient dies.